Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis. - Wikidata - wikimedia - TriplyDB

Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.

Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.

http://www.wikidata.org/entity/Q33926907

about

Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity Understanding the role of antibodies in murine infections with Heligmosomoides (polygyrus) bakeri: 35 years ago, now and 35 years ahead Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain.Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.Differential reliance on autophagy for protection from HSV encephalitis between newborns and adults Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal.Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.The Interleukin-1 Balance During Encephalitis Is Associated With Clinical Severity, Blood-Brain Barrier Permeability, Neuroimaging Changes, and Disease Outcome.CD4 T cell responses in latent and chronic viral infections.The case for immunomodulatory approaches in treating HSV encephalitis.Agents to reduce cytokine storm.Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients Immunoglobulins in adult sepsis and septic shock.Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.Fc glycan-modulated immunoglobulin G effector functions.The protective role of immunoglobulins in fungal infections and inflammation.Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye.Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.Effects of Acyclovir and IVIG on Behavioral Outcomes after HSV1 CNS Infection.IFNγ inhibits G-CSF induced neutrophil expansion and invasion of the CNS to prevent viral encephalitis.Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells.Beneficial effect of a multimerized immunoglobulin Fc in an animal model of inflammatory neuropathy (experimental autoimmune neuritis).Editorial Commentary: Failure of Adjunctive Valacyclovir to Improve Outcomes in Herpes Simplex Encephalitis.Hypothermia and brain inflammation after cardiac arrest

P2860

Q26781290-7E8B0E53-57AD-44D0-BDFA-38EF1D4E8E07 Q27004109-5C8EA6B0-598E-44A8-B5A8-92AC71D48CD2 Q28069362-C824FA07-04CC-4841-81DC-5561909EE66F Q28728886-93F6D3B4-28FF-4E14-9DF3-89422FCE5D59 Q30401056-E0C176B8-C5F6-472B-907F-9610ACE66D3B Q33399238-C51154A8-33E0-4B14-96AB-8B8E1E261BC7 Q33415298-68D7E83D-FC90-4582-8BBE-21BFC459179B Q33981829-B0551749-86D4-488C-B7B0-E7B64C5A3378 Q34876304-D1F2627F-2273-41B6-8373-C3C8721C5827 Q35168425-524B2B98-99D3-4A17-8770-DD031CDBB2DF Q35464299-FEF70C34-A0F8-4D32-9B12-F47FEE18A351 Q35658701-10205AC0-1872-46B1-8C7B-3CFCD82DE588 Q36255087-10972E38-194A-4A2B-B378-72EB91629F2E Q36462680-78F58D4B-E6D1-482B-9621-ADDD786B58B7 Q36765590-F093A02E-23FF-4CFE-A9E7-A5F9B128690B Q36816593-B86C6DCD-CF41-4D76-9B88-94A73D4C5419 Q36837631-637B87C8-AC69-4DF1-89FC-7A746DE6F6B6 Q37091308-E7E4ABE5-4CB4-4825-8E9B-18657E08EC56 Q37577684-E840546F-8D41-44D2-A63B-95FCC84C69EA Q37732919-A2FB78E9-C9B1-4DDB-AB74-5A10EBCFEA4D Q38034107-BC8FFBCC-ECF9-4810-A14B-AB30DD973948 Q38133405-37BC88D7-10B4-4C89-97B0-E4D4B37BFA21 Q38206710-FE4C0E02-3521-4DBF-A6C8-553BDAEEFA5E Q38268922-F46E9CDA-1ED3-456F-A09C-37C8A95039A7 Q38304255-29FB8A3E-FD8E-4563-95E5-DCD31D1038CD Q38478867-C0130BC9-316A-4B39-92E6-D2A3579C1A56 Q38820288-76E28E53-A0BE-4F98-B64F-EF46834CB369 Q38900642-1FC1E9F3-F606-473E-AB81-2AA9DF08EF69 Q47550160-C9B66BED-04E8-4462-B7B3-F99E539AB6B4 Q47551082-3CC02516-EDB5-4FAB-9B2F-267F77893D0B Q49168156-1672EAD1-D3F0-4ACF-A90B-A38DDED49A63 Q50895051-0312824F-A075-479F-BDBD-76F91F6507D8 Q51022297-6D628855-337D-4701-AEC1-A4A09567E0F6 Q57149107-28F66DFA-0E70-46BF-9954-1E827AECDBAD

P2860

Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.

http://www.wikidata.org/entity/Q33926907

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Passively administered pooled ...... gainst fatal HSV encephalitis.

@ast

Passively administered pooled ...... gainst fatal HSV encephalitis.

@en

type

label

Passively administered pooled ...... gainst fatal HSV encephalitis.

@ast

Passively administered pooled ...... gainst fatal HSV encephalitis.

@en

prefLabel

Passively administered pooled ...... gainst fatal HSV encephalitis.

@ast

Passively administered pooled ...... gainst fatal HSV encephalitis.

@en

P1433

Q33926907-72DFF399-9D5C-4D60-A745-CAD9CDC391A0

P1476

Q33926907-0CE0510E-C488-4D8A-AB07-24FE0F239196

P2093

Q33926907-694E9FB6-68CB-478B-A6BB-F7EA5537B5C2

Q33926907-C52E1C6C-98E8-458B-831A-7EDB4AB45AA9

Q33926907-D1FAAD84-3064-4AAE-A2AE-F44AAC24C822

Q33926907-D3CBBEC0-675C-4212-839B-F85D9330A905

P2860

Q33926907-05476C2E-3D4F-4EC4-B5F3-7D65D60FFB7E

Q33926907-081AB007-B078-49C8-9A5E-166F51654598

Q33926907-167AD597-60EE-4A42-BFCF-BD639F9FF33C

Q33926907-26105D66-FD06-481C-8345-9431FC9BE758

Q33926907-31EB13BA-DF51-4A5C-A18B-D9F16BA7A858

Q33926907-35A62882-7CD9-438D-9458-16249378C81A

Q33926907-35C86235-C1ED-4483-8148-3D4134870E8C

Q33926907-371936A3-5394-407E-BAF5-08F97301CF4F

Q33926907-3C73DBE7-FF3F-4D04-945C-617ADC7B1792

Q33926907-414F8D17-EF7F-4129-94DE-10437AFB9256

P304

Q33926907-15397EA8-1197-4441-9036-546C5F17E759

P31

Q33926907-A2BFCC5B-5D97-4DDB-AEAC-5CF0602A4E10

P356

Q33926907-DB1BC5FB-2D31-47AB-B1F7-4B155B56929D

P433

Q33926907-22BE7CB6-108A-45BC-B30D-1AFF329EA912

P478

Q33926907-6C85D673-12B1-440B-AE16-80E3554318EB

P577

Q33926907-F272AF15-FEAA-4B67-B953-0CDBF8120779

P5875

Q33926907-826C6DB7-C936-4979-8286-11A0A9929CE9

P698

Q33926907-3762CC0C-E252-4215-8162-1CBBB42B20BD

P921

Q33926907-97ADB74F-80EF-4D56-8903-FEFCB618FD31

P932

Q33926907-B778F801-74AF-4FAD-A2C5-377489C98C2E

P356

JOURNAL.PPAT.1002071

P1433

P1476

Passively administered pooled ...... gainst fatal HSV encephalitis.

@en

P2093

Alain N S Newo

http://www.w3.org/2001/XMLSchema#string

Chandran Ramakrishna

http://www.w3.org/2001/XMLSchema#string

Edouard Cantin

http://www.w3.org/2001/XMLSchema#string

Yueh-Wei Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Herpes Simplex: Insights on Pathogenesis and Possible Vaccines

Interleukin-10 and the interleukin-10 receptor

Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"

The antiinflammatory activity of IgG: the intravenous IgG paradox

Myeloid-derived suppressor cells as regulators of the immune system

Anti-inflammatory actions of intravenous immunoglobulin

Fcgamma receptors: old friends and new family members

The regulation of IL-10 production by immune cells

Fcgamma receptors as regulators of immune responses

Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.

P304

e1002071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1002071

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51203171

http://www.w3.org/2001/XMLSchema#string

P698

21655109

http://www.w3.org/2001/XMLSchema#string

P921

P932

3107211

http://www.w3.org/2001/XMLSchema#string